About NOVATARG THERANOSTICS, INC
NOVATARG is pioneering nonequilibrium imaging of membrane proteins to accelerate the development of breakthrough therapeutics for serious diseases, including cancer, diabetes, and infectious diseases like HIV/AIDS and COVID-19.
Nonequilibrium imaging of membrane proteinsRapid and reliable structural analysis of membrane proteinsAccelerated identification of membrane protein targets and therapeuticsImproved specificity of target engagement and reduced development costs
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NOVATARG THERANOSTICS, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.